Quality | 2019.06.21
Study reveals a ‘reconditioning’ process that increases stem cells ability to treat ARDS
A study released today in STEM CELLS Translational Medicine (SCTM) demonstrates how preconditioning mesenchymal stem cells (MSCs) enhances their ability to treat acute respiratory distress disorder (ARDS).
(PRWeb June 20, 2019)
Read the full story at https://www.prweb.com/releases/study_reveals_a_reconditioning_process_that_increases_stem_cells_ability_to_treat_ards/prweb16386963.htm
For more information, please visit
https://www.prweb.com/releases/study_rev[...]o_treat_ards/prweb16386963.htm
